EIDX - Eidos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Eidos Therapeutics's activity chart (see below) currently has 25 price targets and 22 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.11% with an average time for these price targets to be met of 92.33 days.

Most recent stock forecast was given by from BAIRD on 29-Dec-2020. First documented stock forecast 16-Jul-2018.

Best performing analysts who are covering EIDX - Eidos Therapeutics:

Tyler Van Buren Joel Beatty Thomas Shrader Anupam Rama Mani Foroohar

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Dec-2020

$129

$6.79 (5.56%)

$73.26

Buy Since 30-Oct-2019

$59

$-63.21 (-51.72%)

$59

Buy Since 22-Jul-2019

$73.26

$-48.95 (-40.05%)

$80

Show more analysts

Please expand the browser size to see the chart

What is EIDX (Eidos Therapeutics) average time for price targets to be met?

On average it took 92.33 days on average for the stock forecasts to be realized with a an average price target met ratio 86.11

Which analyst has the current highest performing score on EIDX (Eidos Therapeutics) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?

Tyler Van Buren works at TD COWEN and has 48 price targets and 24 ratings on EIDX

Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?

Joel Beatty with highest potential upside - $6.79

Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?

Mani Foroohar with lowest potential downside - -$63.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?